Amplia Therapeutics胰腺癌试验再获四例完全缓解 总体生存数据持续改善

美股速递
Mar 23

生物制药企业AmplIA THERAPEUTICS LTD最新临床数据显示,其针对胰腺癌的ACCENT试验取得突破性进展。该研究在原有成果基础上新增四例完全缓解病例,同时患者总体生存期呈现显著延长趋势。此次数据更新进一步验证了候选药物在晚期胰腺癌治疗领域的潜力,为后续研发提供重要临床依据。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10